Global High-Priority Regulatory Events — September 25, 2026

25-09-2026

Blue Acquisition Corp. filed an 8-K on September 25, 2026, disclosing an updated investor presentation related to its proposed business combination with Blockfusion USA, Inc. The transaction, governed by a Business Combination Agreement (BCA) first signed on November 19, 2025, has been amended six times, with the latest amendment on September 21, 2026. The filing does not provide any financial figures or performance metrics, only procedural and forward-looking statements.

• · The BCA has been amended six times since November 19, 2025, with the most recent amendment on September 21, 2026.
• · The updated investor presentation supersedes an earlier version previously furnished with the SEC.
• · The filing is made under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The transaction involves Blue and Blockfusion becoming wholly-owned subsidiaries of Pubco, which will become a publicly traded company.
• · No financial data, redemption levels, or specific closing conditions are disclosed in this filing.

25-09-2026

Ares Strategic Income Fund filed a final amendment to its Schedule TO, reporting the results of a tender offer that expired on September 18, 2026. The Fund offered to repurchase up to 5% of its outstanding common shares at net asset value (NAV) per share as of August 31, 2026. A total of 50,400,325 shares were validly tendered, but the Fund accepted only 19,264,139 shares (38.2% of those tendered) on a pro-rata basis, paying a total of $515,097,753 at an average price of $26.74 per share.

• · The tender offer was an issuer offer subject to Rule 13e-4, not a third-party offer.
• · Odd-lot priority was given to holders of fewer than 100 shares.
• · The early repurchase deduction was applied to the NAV per share for accepted tenders.
• · The original tender offer statement was filed on August 20, 2026, and amended on September 24, 2026.

25-09-2026

A&Q Long/Short Strategies Fund LLC, a closed-end fund advised by UBS Asset Management (Americas) LLC, has commenced an issuer tender offer to purchase up to $19,000,000 of its limited liability company interests. The offer expires on October 23, 2026, at 12:00 midnight New York time. The fund's assets will be reduced by the amount of interests purchased, which may affect income relative to assets, but no earnings or book value per share data is available as the fund has no shares.

• · The tender offer is an issuer tender offer subject to Rule 13e-4 under the Securities Exchange Act of 1934.
• · The Fund is a closed-end, non-diversified management investment company organized as a Delaware limited liability company.
• · The Fund's audited financial statements for the year ended December 31, 2024, were filed on Form N-CSR on March 10, 2025.
• · The Fund's audited financial statements for the year ended December 31, 2025, were filed on Form N-CSR on March 6, 2026.
• · The Fund's unaudited financial statements for the six-month period ended June 30, 2026, were filed on Form N-CSR on August 28, 2026.
• · The Fund does not have shares and therefore has no earnings per share or book value per share information.
• · The Fund's assets will be reduced by the amount of Interests purchased, potentially affecting income relative to assets.

25-09-2026

BlackRock Alpha Strategies Fund has announced an issuer tender offer to repurchase up to 25% of its outstanding common shares (Class A and Class I) as of September 1, 2026, for cash at a price equal to the NAV per share determined as of December 31, 2026. The offer, which is not a going-private transaction, is being made to provide liquidity to shareholders in the absence of an established trading market for the shares. This buyback represents a significant capital return to shareholders, though the final repurchase price and the actual number of shares tendered are contingent on the NAV calculation at the end of the offer period.

• · The Trust is a non-diversified closed-end management investment company.
• · There is no established trading market for the Shares.
• · Principal executive offices: 100 Bellevue Parkway, Wilmington, Delaware 19809.
• · The tender offer is scheduled to expire on December 31, 2026, or a later date if extended.
• · No persons have been retained to make solicitations or recommendations in connection with the Offer.

25-09-2026

Silexion Therapeutics Corp (SLXN/SLXNW) disclosed on September 25, 2026 that it received a Nasdaq Staff letter notifying the company that its ordinary share closing bid price has been below the $1.00 minimum for 30 consecutive business days, triggering a potential delisting review under Nasdaq Listing Rule 5550(a)(2). The Nasdaq hearings panel will consider the bid price deficiency in its decision on whether to allow Silexion to remain listed on the Nasdaq Capital Market. The letter has no immediate effect on trading of the ordinary shares (SLXN) or warrants (SLXNW), which continue to trade as usual pending the panel's decision.

• · The company is classified as an 'emerging growth company' under SEC Rule 405 and Rule 12b-2.
• · The company's principal executive offices are located in Ramat-Gan, Israel.
• · The company has not elected to use the extended transition period for complying with new or revised financial accounting standards.
• · The filing includes standard forward-looking statement disclaimers and risk factor references to the company's 2025 Form 10-K.

25-09-2026

SANUWAVE Health, Inc. received a Nasdaq notice on September 23, 2026, for failing to maintain the minimum Market Value of Listed Securities (MVLS) of $50,000,000, as its MVLS remained below this threshold for 30 consecutive business days. The company has a 180-day compliance period until March 22, 2027, to regain compliance, with no immediate impact on its Nasdaq Global Market listing. Management is evaluating options, including a potential transfer to the Nasdaq Capital Market, but there is no assurance of maintaining the listing.

• · Compliance deadline is March 22, 2027, to regain MVLS of at least $50,000,000 for 10 consecutive business days.
• · If compliance is not regained, the company will receive written notification that its securities are subject to delisting.
• · The company may consider transferring its listing to The Nasdaq Capital Market if it meets the applicable continued listing requirements.

25-09-2026

Dabur India Limited announced that the NCLT has sanctioned the Scheme of Amalgamation of Sesa Care Private Limited with Dabur India, marking a key milestone in the transaction first announced in October 2024. The merger will integrate the premium Ayurvedic hair care brand Sesa Care into Dabur's portfolio, with an appointed date of April 1, 2026. The company expects to leverage its distribution network and category expertise to expand Sesa Care's reach and unlock revenue and cost synergies.

• · Dabur India initially acquired 51% of the paid-up Cumulative Redeemable Preference Shares (CRPS) of Sesa Care from True North in October 2024.
• · The Scheme received requisite approvals from Dabur India's equity shareholders and unsecured creditors on May 2, 2026.
• · The merger will become effective upon completion of necessary statutory filings and other conditions stipulated under the Scheme.
• · Dabur's products reach 8 out of every 10 Indian households.

25-09-2026

The Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench-I, has approved the resolution plan submitted by Advaita Trading Private Limited for Zicom Electronic Security Systems Limited under the Insolvency and Bankruptcy Code, 2016. The plan was approved by the Committee of Creditors with a 75.46% voting share, but the NCLT had previously returned the plan for reconsideration due to concerns over feasibility, viability, and valuation, particularly regarding intangible assets. The resolution professional has now been replaced, and the plan has been re-approved by the NCLT.

• · The CIRP commenced on 29.07.2022 under Section 7 of the IBC.
• · The resolution plan was originally submitted on 12.05.2023 and revised multiple times.
• · The NCLT had previously returned the plan on 03.06.2025 citing non-compliance with Section 30(2) of the Code and Regulation 38(3)(b) of the CIRP Regulations.
• · The resolution professional was replaced on 04.09.2025 with a 76.83% voting share.
• · An exclusion of 742 days from 24.08.2023 to 04.09.2025 was granted.
• · The CIRP period was extended multiple times, with the latest extension of 30 days from 04.12.2025.

25-09-2026

Arambhveer Limited has announced a mandatory open offer to acquire up to 21,81,121 equity shares (26.00% of voting capital) of Mapro Industries Limited at ₹60.13 per share, aggregating ₹13,11,50,806, in compliance with SEBI (SAST) Regulations. The offer follows a share purchase agreement for 21,85,430 shares (26.05%) at ₹30.00 per share, and the acquirer will gain control upon completion. The offer price is at a premium to the underlying transaction price, but the public shareholding may fall below the minimum required, necessitating compliance measures.

• · The offer price of ₹60.13 per share is a 100.4% premium over the underlying transaction price of ₹30.00 per share.
• · The target company's equity shares are listed only on BSE (Scrip Code: 509762, Scrip ID: MAPROIN).
• · The detailed public statement is to be published on or before October 01, 2026.
• · The tendering period is 10 working days as per SEBI (SAST) Regulations.
• · The acquirer and sellers have entered into a share purchase agreement dated September 24, 2026.
• · The public shareholding may fall below the minimum required level, and the acquirer will need to take steps to comply with SEBI LODR and SCRR rules.

25-09-2026

Denis Chem Lab Limited announced that shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for a three-year term from August 1, 2026 to July 31, 2029, at the 45th Annual General Meeting held on September 25, 2026. Dr. Patel has over seven decades of experience in the medical and pharmaceuticals field. The filing confirms he is not debarred by any SEBI order or other authority.

• · Dr. Patel holds DIN 00087114 and has qualifications B.E., M.S., Ph.D.
• · The re-appointment was approved via Special Resolution at the 45th AGM held through VC/OAVM.
• · Dr. Himanshu C. Patel, Ms. Anar H. Patel, and Mr. Dinesh B. Patel are related to each other.

25-09-2026

Jatalia Global Ventures Ltd, under CIRP, announced the cessation of three erstwhile directors effective 09.07.2026, following NCLT approval of its resolution plan submitted by Norfolk Technology Services Ltd. The board also appointed Ms. Manshi Gandhi as Company Secretary & Compliance Officer effective 24.09.2026. This marks a key step in the company's restructuring and plan implementation.

• · NCLT order dated 09.07.2026 approved the resolution plan in CP No. IB-263/ND/2023.
• · New directors were appointed on 08.09.2026 and intimated to BSE.
• · Board meeting held on 24.09.2026 via video conferencing.
• · Cessation of erstwhile directors effective from 09.07.2026.
• · Ms. Manshi Gandhi is an Associate member of ICSI with membership number 60088.

25-09-2026

Antariksh Industries Ltd has undergone a change in control: the new promoters, Mr. Alpitkumar Pravinchandra Gor and Riddhi Infocom Solutions LLP, have acquired a 64.81% stake through a combination of a share purchase from the erstwhile promoter, an open offer, and a preferential allotment. The outgoing promoter, Mrs. Gitaben Nitinbhai Patel, has ceased to hold any equity shares and has applied for reclassification from 'promoter' to 'public' category. The acquisition was completed pursuant to a Share Purchase Agreement dated June 26, 2026, and the open offer process.

• · The outgoing promoter, Mrs. Gitaben Nitinbhai Patel, no longer holds any equity shares in the Company.
• · The new promoters hold a combined 64.81% of the equity share capital.
• · The Acquirer (Mr. Alpitkumar Pravinchandra Gor) holds 34.66% and the PAC (Riddhi Infocom Solutions LLP) holds 30.15%.
• · A preferential allotment of 7,78,750 shares to the Acquirer and 6,34,800 shares to the PAC was completed on 25/09/2026.
• · The outgoing promoter has applied for reclassification from 'promoter' to 'public' category under Regulation 31A of the LODR Regulations.

25-09-2026

Vas Infrastructure Ltd, undergoing Corporate Insolvency Resolution Process (CIRP) since March 2024, disclosed that its promoter Mr. Jayesh Valia's settlement proposal under Section 12A of the IBC was rejected by the sole secured financial creditor, Canara Bank, on September 24, 2026. The CIRP will continue as per the IBC provisions, with no resolution or settlement achieved.

• · CIRP was initiated by NCLT Mumbai Bench order dated March 11, 2024, in C.P. (IB) No. 314/MB/2023.
• · Mr. Bimal Kumar Agarwal was appointed as Resolution Professional on August 13, 2026 (order uploaded August 24, 2026).
• · Canara Bank holds 100% voting share in the Committee of Creditors.
• · The promoter's proposal was submitted on September 23, 2026, and rejected the next day.

25-09-2026

Magnum Ventures Limited has informed the exchanges that the NCLT Allahabad Bench has pronounced its order on September 22, 2026, in relation to the First Motion Application for a Scheme of Arrangement between Magnum Ventures (Demerged Company) and its wholly owned subsidiary Magnum Paperz Limited (Resulting Company). The scheme involves the demerger of the Paper Business from Magnum Ventures into Magnum Paperz, along with a reduction of share capital of the Demerged Company and cancellation of the pre-scheme share capital of the Resulting Company. The order was uploaded on the NCLT portal on September 25, 2026.

• · The Demerged Company (Magnum Ventures) has two business verticals: Paper Business (manufacturing paper from wastepaper) and Hotel Business (Five Star Hotel under 'Country Inn & Suites by Radisson', certified all-vegetarian by HRACC, Ministry of Tourism).
• · The Resulting Company (Magnum Paperz Limited) was incorporated on September 22, 2025, as a wholly owned subsidiary of Magnum Ventures.
• · The scheme includes a reduction of share capital of the Demerged Company to realign capital structure with the residual Hotel Business, and cancellation of the pre-scheme share capital of the Resulting Company to avoid duplication of economic interests.
• · The NCLT order dispensed with meetings of Preference Shareholders of the Demerged Company and Equity Shareholders and Unsecured Creditors of the Resulting Company based on consent affidavits, and directed convening of meetings of Equity Shareholders, Secured Non-Convertible Debenture Holders, Secured Creditors, and Unsecured Creditors of the Demerged Company via video conferencing with remote e-voting.
• · The scheme is intended to provide focused management, operational flexibility, optimized capital structures, and independent growth for each business vertical.

25-09-2026

Paramount Skydance Corp (PSKY) announced it will voluntarily transfer its stock listing from Nasdaq to the NYSE effective October 6, 2026, and set a record date of October 5, 2026 for a distribution of warrants to purchase Class B common stock. The warrant distribution—expected to be approximately 470 million warrants—is contingent on the closing of the pending Warner Bros. Discovery merger, which remains uncertain with no assurance on timing or completion. The warrants will have an exercise price between $12.00 and $16.02 per share, expire 10 years after issuance, and may be redeemed early if the stock price hits $30.00 for 20 out of 30 consecutive trading days after the third anniversary, while certain holders and plans are excluded or receive shares instead.

• · The warrant distribution excludes Restricted Holders (Lawrence J. Ellison, David F. Ellison, Gerald J. Cardinale, the Lawrence J. Ellison Revocable Trust, and RedBird Capital Partners Fund IV) and their affiliates, as well as the Paramount Global 401(k) Plan and Paramount Global Master Trust (which will receive shares instead of warrants).
• · The warrants will trade separately on the NYSE if approved.
• · The Company may cancel or postpone the record date and/or issue date at its discretion if the WBD Merger does not close as expected.

25-09-2026

Netcapital Inc. received a Nasdaq notice on September 21, 2026, for failure to comply with Listing Rule 5250(c)(1) due to delinquent filing of its Form 10-K (fiscal year ended April 30, 2026) and Form 10-Q (quarter ended July 31, 2026). The company has until October 23, 2026, to submit a compliance plan, and if accepted, may receive an exception until February 9, 2027. While the notice has no immediate effect on trading, the company faces potential delisting risk if it fails to regain compliance.

• · The company remains delinquent in filing its Form 10-K for the fiscal year ended April 30, 2026, and its Form 10-Q for the quarter ended July 31, 2026.
• · The company has until October 23, 2026, to submit a plan to regain compliance with Nasdaq.
• · If Nasdaq accepts the plan, the company may receive an exception of up to 180 calendar days, until February 9, 2027, to regain compliance.
• · The company's common stock will continue to trade on The Nasdaq Capital Market under the symbol 'NCPL' pending compliance.
• · The company issued a press release on September 25, 2026, announcing the receipt of the Notice, as required by Nasdaq Listing Rule 5810(b).

25-09-2026

Future Money Acquisition Corporation (FMAC) received a Nasdaq deficiency notice on September 22, 2026, for failing to timely file its quarterly report (Form 10-Q) for the period ended July 31, 2026, violating Nasdaq Listing Rule 5250(c)(1). The company has 60 days (until November 23, 2026) to submit a compliance plan, and if accepted, Nasdaq may grant an exception until March 22, 2027. While the company is working to file the Form 10-Q, it cautions that there is no assurance it will regain compliance or meet the conditions of any exception.

• · The notice has no immediate effect on the listing or trading of FMAC's securities on Nasdaq.
• · If Nasdaq does not accept the plan, the company may appeal to a Nasdaq Hearings Panel.
• · The company's securities include units (FMACU), ordinary shares (FMAC), and rights (FMACR), all listed on Nasdaq.

25-09-2026

NMP Acquisition Corp. (SPAC) has entered into Amendment No. 1 to its Business Combination Agreement with GTS Holdings, Inc. (Pubco) and GTS Holdings, LLC (the Company), extending the deadline for delivering audited financial statements from 15 days after the original agreement (September 4, 2026) to October 9, 2026. The amendment also grants SPAC the unilateral right to further extend the delivery dates at its sole discretion, and retroactively waives any prior breach for late delivery. This extension suggests the target company is behind schedule on providing PCAOB-audited financials, a critical step for completing the de-SPAC merger, but the parties remain committed to the transaction.

• · Original deadline for Company Audited Financials was 15 calendar days from September 4, 2026 (i.e., September 19, 2026).
• · New deadline for both Company Audited Financials and Pubco Audited Financials is October 9, 2026.
• · SPAC may extend either or both deadlines unilaterally, for any period, on one or more occasions, without further consent.
• · The amendment retroactively cures any prior breach for failure to deliver financials before the amendment date.
• · The Pubco Audited Financials are not subject to the same conditions (Sections 6.12(a) and 8.1(h)) as the Company Audited Financials.
• · The Outside Date (final termination date) of the Business Combination Agreement is not amended.

25-09-2026

Southland Holdings, Inc. received a delisting notice from NYSE American on September 23, 2026, for failing to meet continued listing standards due to a stockholders' deficit of $248.2 million and net losses in the last three fiscal years. The company must submit a compliance plan by October 23, 2026, and has until March 23, 2028, to regain compliance. While the stock and warrants continue trading for now, failure to submit or execute an acceptable plan will trigger delisting proceedings.

• · The company reported net losses in its last three fiscal years and is not eligible for any exemption under Section 1003(a) of the NYSE American Company Guide.
• · The compliance plan deadline is October 23, 2026, and the cure period extends to March 23, 2028.
• · If the plan is accepted but compliance is not achieved by March 23, 2028, or progress is insufficient, delisting proceedings will commence.
• · The company may appeal a staff delisting determination under Section 1010 and Part 12 of the Company Guide.
• · The notice does not affect business operations or SEC reporting obligations.

25-09-2026

On September 25, 2026, Dyadic International received a Nasdaq deficiency notice for failing to maintain the minimum bid price of $1.00 per share for 30 consecutive business days, as well as a separate notice for failing to maintain the minimum Market Value of Listed Securities (MVLS) of $35 million. The company has until March 24, 2027, to regain compliance with both requirements, though there is no immediate impact on its Nasdaq listing. The company plans to monitor its stock price and evaluate options, including a potential reverse stock split, to regain compliance.

• · Compliance Date for both bid price and MVLS deficiencies is March 24, 2027
• · Company may be eligible for an additional 180-day compliance period if it meets MVLS and other initial listing standards on the Compliance Date
• · If compliance is not regained, Nasdaq Staff will provide written notification that the common stock is subject to delisting
• · Company may appeal any delisting determination to a hearings panel, but there is no assurance of success
• · Company intends to actively monitor bid price and MVLS and evaluate options including a potential reverse stock split

25-09-2026

Fusemachines Inc. (FUSEW) received a Nasdaq delisting notice on September 24, 2026, for failing to maintain the minimum Market Value of Listed Securities (MVLS) of $50 million required for continued listing on the Nasdaq Global Market. The company had been given 180 days (until September 23, 2026) to regain compliance but failed to do so. Fusemachines plans to request a hearing before the Nasdaq Hearings Panel to stay the delisting, but there is no assurance the Panel will grant continued listing.

• · The company's common stock (FUSE) and warrants (FUSEW) are both traded on Nasdaq and subject to delisting.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new accounting standards.
• · The initial non-compliance notice was received on March 27, 2026.
• · The company plans to request a hearing before the Nasdaq Hearings Panel, which will stay any suspension or delisting action until the hearing and any granted extension expire.

25-09-2026

SilverBox Corp IV received a notice from NYSE Regulation on September 25, 2026, that it has fallen below the continued listing standard requiring a minimum average aggregate global market capitalization of $40,000,000 over 30 consecutive trading days, leading to delisting proceedings. Trading on the NYSE has been suspended, and the company's securities will begin trading on the OTC market on September 28, 2026. The company has the right to appeal the decision to a NYSE committee.

• · The delisting is based on Section 802.01B of the NYSE Listed Company Manual for failing to maintain a $40M average aggregate global market capitalization over 30 consecutive trading days.
• · Trading on the NYSE has been suspended as of the date of the notice (September 25, 2026).
• · OTC trading under the same ticker symbols begins September 28, 2026.
• · The company has the right to appeal the Staff's determination to a Committee of the Board of Directors of the NYSE.

25-09-2026

Calidi Biotherapeutics received a delisting notice from NYSE American on September 21, 2026, for failing to meet the minimum stockholders' equity requirement of $4.0 million, reporting only $3.1 million as of June 30, 2026, and net losses in three of the four most recent fiscal years. The company has until October 21, 2026, to submit a compliance plan and until March 21, 2028, to regain compliance, but faces delisting proceedings if the plan is not accepted or progress is insufficient. The notice does not immediately affect trading, but the stock will carry a '.BC' indicator of noncompliance.

• · The company has until October 21, 2026, to submit a compliance plan to NYSE American.
• · If the plan is accepted, the company must regain compliance by March 21, 2028, or face delisting.
• · The common stock will continue trading under symbol 'CLDI' but with a '.BC' indicator denoting noncompliance.
• · The company reported net losses in three of its four most recent fiscal years ended December 31, 2025.
• · The company is not currently eligible for any exemption from the stockholders' equity requirements.

25-09-2026

Snowdrift Parent Corp filed a preliminary S-4 registration statement on September 25, 2026, in connection with a proposed business combination involving Chemomab Therapeutics Ltd. The filing includes historical financial data for Chemomab for fiscal years 2023-2025 and interim periods, highlighting ongoing R&D and general & administrative expenses, as well as financing arrangements with LifeSci Capital LLC. While the transaction represents a strategic combination, Chemomab's financials show continued operating losses and reliance on capital raises, indicating financial risk.

• · The S-4 filing is preliminary and was filed on September 25, 2026.
• · Chemomab Therapeutics has engaged in multiple financing activities, including private placements (2021, 2024) and ATM agreements (2021-2023), indicating ongoing capital needs.
• · A market offering agreement with Roth Capital Partners was active from October 2023 through December 2025.
• · LifeSci Capital LLC is involved in financing arrangements, with activity from July 2025 through June 2026.
• · The filing includes a subsequent event dated July 7, 2026, related to the combined company and Chemomab securityholders.
• · Financial data covers fiscal years 2023, 2024, and 2025, as well as interim periods in 2025 and 2026, with R&D and G&A expenses broken out separately.

25-09-2026

GCM Grosvenor Core Absolute Return Fund II, LLC (the Fund) announced an issuer tender offer to repurchase up to $16,000,000 of its Shares at net asset value as of December 31, 2026. The offer expires on October 27, 2026, unless extended, and is part of a planned quarterly repurchase program. As of September 1, 2026, the Fund had approximately $71,492,259 in outstanding Shares, and the Adviser and affiliates own only about 0.05% of outstanding Shares, with no executive officers or Directors holding any Shares.

• · The Fund is a closed-end, diversified, management investment company registered under the 1940 Act, organized as a Delaware LLC.
• · Shares are not traded in any market and transfers are strictly limited by the LLC Agreement.
• · The Adviser expects to recommend quarterly repurchases effective as of the last business day of each calendar quarter.
• · The Fund's previous tender offer had an expiration date of July 27, 2026.
• · No executive officer, director, or other affiliate plans to tender Shares in this offer.
• · The Fund's assets will be reduced by the amount of tendered Shares purchased, potentially affecting income relative to assets.

25-09-2026

Hedge Fund Guided Portfolio Solution has launched an issuer tender offer to repurchase up to $33,900,000 of its shares at net asset value as of December 31, 2026. The offer expires on October 27, 2026, unless extended. The fund has approximately $140,494,358 in outstanding shares, and the repurchase represents about 24.1% of outstanding shares. No executive officers or trustees plan to tender shares, and the adviser owns only 0.10% of outstanding shares.

• · The tender offer is an issuer tender offer subject to Rule 13e-4 under the Securities Exchange Act of 1934.
• · Shares are not traded in any market and transfers are strictly limited by the Fund's Declaration of Trust.
• · The Fund expects the Adviser to recommend quarterly repurchases (four times per year) effective as of the last business day of each calendar quarter.
• · The previous tender offer had an expiration date of July 27, 2026.
• · No persons have been retained or compensated to make solicitations or recommendations in connection with the offer.
• · The Fund's assets will be reduced by the amount of tendered shares purchased, potentially affecting income relative to assets.

25-09-2026

Pinnacle Acquisition Corp, a SPAC, announced the separate trading of its Class A ordinary shares and rights effective September 25, 2026, following its $200M IPO on August 10, 2026. The underwriters' over-allotment option expired unexercised, resulting in the forfeiture and cancellation of 750,000 Class B ordinary shares by the sponsor to maintain 20% ownership. The company is actively seeking a business combination target in commercial/consumer finance and adjacent financial services sectors.

• · The company is a blank check company (SPAC) incorporated in the Cayman Islands.
• · The company intends to focus its search on businesses in commercial finance, consumer finance, and adjacent financial services sectors, including technology-enabled platforms and specialty finance.
• · The company's leadership team includes Steven K. Hudson (CEO, Chairman), Andrew Rechtschaffen (Co-founder, Director), and Jack Schneider (CFO).
• · The company's transfer agent is Continental Stock Transfer & Trust Company.

25-09-2026

A&Q Technology Fund LLC filed a final amendment to its tender offer statement, reporting that its offer to repurchase up to $26,000,000 of its limited liability company interests expired on April 16, 2026. Only $8,293,380 in interests were validly tendered and accepted, representing a take-up rate of approximately 31.9% of the maximum offer amount. The filing is a routine procedural update with no additional financial or operational context.

• · The tender offer expired at midnight New York time on April 16, 2026.
• · All validly tendered interests were accepted and paid for by the Fund.
• · The filing is a final amendment (SC TO-I/A) reporting results, not a new offer.

25-09-2026

A&Q Multi-Strategy Fund completed its issuer tender offer, expiring April 16, 2026, with $10,590,116 of shares validly tendered and accepted for purchase, well below the $60,000,000 maximum. The final amendment reports the results, indicating limited shareholder participation in the offer.

• · The tender offer expired at 12:00 midnight New York time on April 16, 2026.
• · All validly tendered shares were accepted for purchase and paid for by the Fund.
• · The offer was an issuer tender offer subject to Rule 13e-4.
• · The filing is a final amendment reporting the results of the tender offer.

25-09-2026

Inflection Point Acquisition Corp. V (IPEXU), a blank check company, has been delisted from Nasdaq effective September 25, 2026, as notified by Nasdaq Stock Market LLC in a Form 25-NSE filing. The delisting applies to its Class A Ordinary Shares, Rights, and Units under SEC Rule 12d2-2(a)(3). The company, formerly known as Maywood Acquisition Corp., is incorporated in the Cayman Islands.

• · Delisting effective date: September 25, 2026
• · SEC file number: 001-42518
• · Company formerly known as Maywood Acquisition Corp. (name change June 26, 2024)
• · Incorporated in the Cayman Islands
• · Business address: 167 Madison Ave, Suite 205, New York, NY 10016

25-09-2026

The filing is a tender offer by Ares Core Infrastructure Fund, but no specific financial details, deal structure, or strategic rationale are disclosed. The document is a standard SEC filing with no quantitative data, named entities, or scheduled events. As a result, the analysis is limited to the filing's existence and basic metadata.

• · Filing date: September 25, 2026
• · SEC Accession Number: 0001104659-26-110967
• · File size: 158 KB
• · Sector: not specified

25-09-2026

Lumen Technologies voluntarily notified the NYSE of its intention to delist its common stock and certain Qwest Corporation notes, with the listing transferring to Nasdaq. The transfer is expected to be effective on October 6, 2026, with the same trading symbols maintained. CEO Kate Johnson framed the move as aligning with Lumen's transformation into an enterprise networking company for AI.

• · The delisting from NYSE is expected at the close of trading on October 5, 2026, and listing on Nasdaq at the opening on October 6, 2026.
• · The Securities include Common Stock (LUMN), Preferred Stock Purchase Rights, and Qwest Corporation's 6.500% Notes due 2051 (CTGG) and 6.750% Notes due 2052 (CTHH).
• · Registration of transfer was approved by the boards of both Lumen and Qwest Corporation.

25-09-2026

Destiny Alternative Fund has announced an issuer tender offer to repurchase up to 5.00% of its net assets, approximately $4,100,000 (352,234 Shares as of June 30, 2026). Shareholders may tender all or some of their shares by October 27, 2026, with the purchase price based on net asset value as of December 31, 2026. Payment will be made via a non-interest bearing promissory note, with an initial cash payment of at least 95% of the unaudited value and a post-audit contingent payment for any excess.

• · The Fund is a closed-end, non-diversified management investment company registered under the 1940 Act, organized as a Delaware statutory trust.
• · Shares are not traded on any established market; transfers are strictly limited by the Fund's Agreement and Declaration of Trust.
• · The Fund invests primarily in hedge funds, private equity funds, growth equity funds, venture capital funds, and other alternative investment vehicles.
• · The Investment Adviser is First Trust Capital Management L.P., located at 225 W. Wacker Drive, Suite 2160, Chicago, Illinois 60606.
• · The Offer is not conditioned on any minimum number of Shares being tendered.
• · Shareholders may withdraw tenders at any time before the Notice Due Date (October 27, 2026) and also after that date if the Fund has not yet accepted the tender.
• · The Fund reserves the right to cancel, amend, or postpone the Offer at any time before the Notice Due Date.
• · The purchase price will be paid entirely in cash, sourced from cash on hand, sale of portfolio holdings, or borrowings.
• · The Post-Audit Payment will be made within 5 business days after completion of the Fund's next annual audit (expected by end of May 2027).

25-09-2026

zSpace, Inc. (ZSPC) filed Form 25 with the SEC on September 25, 2026, to voluntarily withdraw its common stock from listing and registration on The Nasdaq Stock Market LLC. The delisting is effective as of the filing date, and the company certifies compliance with Nasdaq rules and SEC requirements for voluntary withdrawal. This move removes the company's shares from public trading on a major U.S. exchange, significantly reducing liquidity and transparency for shareholders.

• · Commission File Number: 001-42431
• · Par value of common stock: $0.00001 per share
• · Delisting is voluntary under 17 CFR 240.12d2-2(c)
• · Principal executive offices: 226 Airport Parkway, San Jose, CA 95110

25-09-2026

Antares Private Credit Fund filed Amendment No. 1 to its Schedule TO, reporting preliminary results of its tender offer to repurchase up to 5% of its outstanding Class I shares. As of the September 11, 2026 expiration, only 147,606.240 shares (0.45% of outstanding) were tendered and not withdrawn, well below the 5% maximum. The Fund will repurchase 100% of tendered shares at a price based on the September 30, 2026 NAV, to be disclosed in November 2026.

• · Tender offer expired at 11:59 p.m. Eastern Time on September 11, 2026.
• · The Fund intends to repurchase 100% of the requested amounts.
• · Purchase price per share will be determined based on net asset value as of September 30, 2026 and disclosed in November 2026.
• · This is Amendment No. 1 to the original Schedule TO filed on August 14, 2026.

25-09-2026

GCM Grosvenor Core Absolute Return Fund I, LLC (formerly Grosvenor Registered Multi-Strategy Fund (TI 1), LLC) has commenced a tender offer to repurchase up to $16,000,000 of its Shares at net asset value, with the offer expiring on October 27, 2026. The Fund is a closed-end management investment company, and shares are not publicly traded. The Fund's adviser and affiliates own only 0.31% of outstanding shares, and no executive officers or directors hold shares. The offer is subject to conditions, including the Fund's right to extend or withdraw tenders under Rule 13e-4.

• · The Fund's audited financial statements for fiscal year ended March 31, 2025, were filed on Form N-CSR on June 9, 2025, and for fiscal year ended March 31, 2026, on June 8, 2026.
• · The Fund is not required to file quarterly unaudited financial statements under the Securities Exchange Act of 1934.
• · The Fund's Board will call a meeting of Investors to consider dissolution if the Fund does not repurchase Shares at least once during any 24-month period.
• · No executive officer, director, or affiliate plans to tender Shares in the offer.
• · The Fund has no plans to purchase Shares from executive officers, directors, or affiliates pursuant to the offer.

25-09-2026

GCM Grosvenor Core Absolute Return Master Fund, LLC (formerly Grosvenor Registered Multi-Strategy Master Fund, LLC) announced an issuer tender offer to repurchase up to $32,000,000 of its limited liability company interests at net asset value. The offer expires on October 27, 2026, with the purchase price determined as of December 31, 2026. The fund had approximately $131,543,522 in outstanding interests as of September 1, 2026, and the repurchase represents about 24.3% of outstanding interests. The fund's adviser expects to recommend quarterly repurchases, but the fund has no plans to purchase interests from any executive officers or directors.

• · The fund is a closed-end, diversified, management investment company registered under the Investment Company Act of 1940.
• · Interests are not traded in any market and transfers are strictly limited by the LLC Agreement.
• · The adviser or its affiliates own only 0.01% of outstanding interests; no executive officers or directors own any interests.
• · The previous tender offer had an expiration date of July 27, 2026.
• · The fund's assets will be reduced by the amount of tendered interests purchased, potentially affecting income relative to assets.
• · The fund is not required to file quarterly unaudited financial statements.

25-09-2026

The New York Stock Exchange (NYSE) notified the SEC of its intent to delist and deregister the guarantor of PETROBRAS' 5.999% Global Notes due 2028, effective October 6, 2026. The delisting follows the full redemption, maturity, or retirement of the entire class of these securities on September 25, 2026, with sufficient funds deposited and made available to holders. Trading of the security was suspended on the same date.

• · The delisting is effective at the opening of business on October 6, 2026.
• · The security was suspended from trading on September 25, 2026.
• · The filing is made under 17 CFR 240.12d2-2(a)(1), indicating the entire class was called for redemption, maturity, or retirement.
• · Funds sufficient for payment were deposited with an authorized agency and made available to security holders on September 25, 2026.

25-09-2026

The New York Stock Exchange filed a Form 25-NSE to delist and deregister the 5.999% Global Notes due 2028 issued by Petrobras Global Finance B.V., effective October 6, 2026. The delisting follows the full redemption, maturity, or retirement of the notes on September 25, 2026, with sufficient funds deposited and made available to holders. Trading in the securities was suspended on September 25, 2026.

• · The delisting is effective at the opening of business on October 6, 2026.
• · The securities were called for redemption, maturity, or retirement on September 25, 2026.
• · Funds sufficient for payment were deposited with an authorized agency and made available to holders on September 25, 2026.
• · Trading was suspended on September 25, 2026.

25-09-2026

IFF's 1.800% Senior Notes due 2026 were redeemed at maturity on September 25, 2026, and the NYSE filed a Form 25-NSE to delist and deregister the entire class of these notes, effective at the opening of business on October 6, 2026. Trading in the notes was suspended on the maturity date. This is a routine debt retirement event with no financial impact on IFF's equity or operations.

• · The delisting is effective at the opening of business on October 6, 2026.
• · Trading was suspended on September 25, 2026, the maturity date.
• · The filing cites 17 CFR 240.12d2-2(a)(2) as the basis for removal.